N@N

Market Maker Surveillance Report. QTWW, AEN, DANG, AFFY, GTHP, OMBP, Winning Stocks With Lowest Price Friction For Thursday, D

December 8, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 3501 companies with "abnormal" market making, 1283 companies with positive Friction Factors and 4994 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Thursday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. QUANTUM FUEL SYSTEMS TECHNOL (NASDAQ:QTWW), ADEONA PHARMACEUTICALS INC (AMEX:AEN), E-COMMERCE CHINA-SPON ADR (NYSE:DANG), AFFYMAX INC (NASDAQ:AFFY), GUIDED THERAPEUTICS INC (OTC:GTHP), OMNI BIO PHARMACEUTICAL INC (OTCBB:OMBP). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     QTWW       $0.320       22.38%       101,170         56.51%       76,768          42.88%       24,402          763     
     AEN        $0.140       12.49%       354,395         31.05%       329,008         28.82%       25,387          1,813   
     DANG       $0.920       19.78%       2,061,722       32.03%       1,965,766       30.54%       95,956          1,043   
     AFFY       $2.140       36.57%       10,792,689      50.35%       10,327,936      48.18%       464,753         2,172   
     GTHP       $0.160       16.67%       218,184         46.91%       207,383         44.58%       10,801          675     
     OMBP       $0.380       14.62%       44,535          60.53%       29,039          39.47%       15,496          408     

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows QTWW with a dollar gain Thursday of $0.32000 and a Friction Factor of 763 shares. That means that it only took 763 more shares of buying than selling to move QTWW higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

QUANTUM FUEL SYSTEMS TECHNOL (NASDAQ:QTWW) - Quantum Fuel Systems Technologies Worldwide, Inc., an integrated alternative energy company, engages in the development and production of propulsion systems, energy storage technologies, and alternative fuel vehicles. Its portfolio of technologies include lithium-ion battery systems, electronic controls, hybrid electric drive and control systems, hydrogen storage and metering systems, and other alternative fuel technologies. The company also engages in powertrain engineering; system integration; manufacturing and assembly of packaged fuel systems; and the provision of battery control systems for vehicles and other applications, including fuel cells, hybrids, plug-in electric hybrid, alternative fuels, and hydrogen refueling stations and systems. Its powertrain engineering, system integration, and assembly capabilities provide fast-to-market solutions to support the production of hybrid and plug-in hybrid, hydrogen-powered hybrid, fuel cell, and alternative fuel vehicles, as well as modular and transportable hydrogen refueling stations. In addition, the company designs, engineers, and manufactures hybrid and fuel cell vehicles. Its customer base includes automotive original equipment manufacturers, military and governmental agencies, aerospace, and other strategic alliance partners. The company operates primarily in the United States, Germany, Iceland, Japan, and Norway. Quantum Fuel Systems Technologies has strategic alliances with General Motors; Fisker Automotive, Inc.; Asola; Advanced Lithium Power, Inc.; Power Control and Design, Inc.; and Shigan Quantum Technologies PVT LTD. The company was founded in 2000 and is headquartered in Irvine, California.

ADEONA PHARMACEUTICALS INC (AMEX:AEN) - Adeona Pharmaceuticals, Inc. operates as a pharmaceutical company that develops medicines for central nervous systems and autoimmune diseases. It primarily focuses to in-license clinical-stage drug candidates that have already demonstrated a certain level of clinical efficacy and develop them further to either commercialization or development collaboration. The company is developing various clinical-stage drug candidates that include Trimesta, an investigational oral drug for the treatment of relapsing remitting multiple sclerosis; Zinthionein, an oral, gastro-retentive, and sustained-release medical food candidate for the dietary management of Alzheimers disease and mild cognitive impairment; and Effirma, a centrally-acting investigational oral drug for the treatment of fibromyalgia syndrome. It is also developing dnaJP1, an investigational oral drug for the treatment of rheumatoid arthritis; and CD4 Inhibitor 802-2, an investigational drug for the prevention of severe graft-versus-host disease. In addition, the company engages in commercializing serum-based diagnostic tests, including the CopperProof Panel to assist physicians in identifying patients with zinc deficiency and patients at risk of chronic copper toxicity due to impaired serum copper binding. Further, it involves in the manufacture, testing, and clinical development of tetrathiomolybate for Alzheimers, Parkinsons, and Huntingtons diseases. Adeona Pharmaceuticals, Inc. has a partnership with Meda AB, to develop flupirtine for the treatment of fibromyalgia syndrome. The company was founded in 2001 and is headquartered in Ann Arbor, Michigan.

E-COMMERCE CHINA-SPON ADR (NYSE:DANG) - E-Commerce China Dangdang Inc. operates as a business-to-consumer e-commerce company in the Peoples Republic of China. The company, through its Website, dangdang.com, sells Chinese and foreign language books, music CDs, VCDs, and DVDs, as well as six categories of general merchandise, including beauty and personal care products; home and lifestyle products; baby, children, and maternity products; electronics; apparel and accessories; and footwear, handbags, and luggage. It offers its customers various payment options, such as online payment, wire transfer, and postal remittance. E-Commerce China Dangdang Inc. was formerly known as E-Commerce China Co. Ltd. and changed its name in June 2010. E-Commerce China Dangdang Inc. was incorporated in 2000 and is headquartered in Beijing, China.

AFFYMAX INC (NASDAQ:AFFY) - Affymax, Inc., a biopharmaceutical company, engages in the development of drugs for the treatment of serious and life-threatening conditions. The company is developing Hematide, which is in Phase III clinical trials for the treatment of anemia associated with chronic renal failure. Hematide is a synthetic peptide-based erythropoiesis stimulating agent designed to stimulate production of red blood cells. Affymax, Inc. has strategic alliance agreements with Takeda Pharmaceutical Company Limited and Nektar Therapeutics AL, Corporation to manufacture, develop, and commercialize Hematide. The company was founded in 2001 and is based in Palo Alto, California.

GUIDED THERAPEUTICS INC (OTC:GTHP) - Guided Therapeutics, Inc., a medical technology company, together with its subsidiaries, develops and offers products for the non-invasive cervical cancer detection and diabetes markets. The company is developing a non-invasive cervical cancer detection product using its biophotonic technologies, which could be used to identify cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected or emanating from the cervix to produce a map or image of diseased tissue. Guided Therapeutics has an agreement with Konica Minolta Opto Inc. for the development of LightTouch prototype devices for the esophageal cancer detection application, as well as license agreements with Georgia Tech Research Corporation. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics was founded in 1992 and is based in Norcross, Georgia.

OMNI BIO PHARMACEUTICAL INC (OTCBB:OMBP) - Omni Bio Pharmaceutical, Inc., a biopharmaceutical company, focuses on acquiring, licensing, and developing novel therapies for various medical indications. The company focuses bacterial and viral disorders, biohazards, diabetes, and transplant rejection. Its products include Alpha-1 antitrypsin (AAT) for the treatment of Type 1 diabetes. The companys AAT also targets Type 2 diabetes, influenza, cellular transplantation and graft rejection, anthrax, bacterial pneumonia, and mycobacterium tuberculosis and mycobacterium avium complex. It has license agreements with the Regents of the University of Colorado for patent applications directed to the treatment and/or prevention of bacterial disorders and viral disorders, as well as for technology related to the treatment of cellular transplantation and graft rejection; and Bio Holding, Inc. to obtain a license to patent applications related to the treatment of diabetes. The company is based in Greenwood Village, Colorado.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net